Evaluation of a sparse sampling strategy for determining vancomycin pharmacokinetics in preterm neonates: Application of optimal sampling theory

被引:11
|
作者
Burstein, AH
Gal, P
Forrest, A
机构
[1] MOSES CONE MEM HOSP,GREENSBORO AREA HLTH EDUC CTR,DIV PHARM,GREENSBORO,NC
[2] WOMENS HOSP GREENSBORO,GREENSBORO,NC
[3] UNIV N CAROLINA,DEPT PHARM PRACTICE,CHAPEL HILL,NC
[4] SUNY BUFFALO,DEPT PHARM PRACTICE,BUFFALO,NY 14260
[5] MILLARD FILLMORE HOSP,CLIN PHARMACOKINET LAB,BUFFALO,NY 14209
关键词
vancomycin; pharmacokinetics; neonates;
D O I
10.1177/106002809703100904
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To use optimal sampling theory to determine the fewest vancomycin concentrations required and the appropriate sampling times to calculate vancomycin pharmacokinetic parameters in neonates. DESIGN: Unblinded evaluation in neonates with presumed sepsis. SETTING: Level 3 community-based neonatal intensive care unit. PATIENTS: Eleven neonates with presumed sepsis. INTERVENTIONS: Twelve courses of intravenous vancomycin 20 mg/kg were administered. Blood samples were collected 3 and 9 hours after initiation of a 1-hour infusion of the first dose. MEASUREMENTS AND MAIN RESULTS: A two-compartment model was fit to vancomycin concentrations using iterative two-stage analysis. Pharmacokinetic parameter estimates were used for determination of optimal sampling times for two-, three-, and four-sample concentration data for 100 cases. Relative performance of strategies was compared through calculation and comparison of D efficiency for the determined strategies. Bias (median percent error) and precision (median percent absolute error) of pharmacokinetic parameter estimates for each strategy in the 100 simulated cases were determined. CONCLUSIONS: For estimation of total clearance and volume in the central and peripheral compartments, all strategies performed similarly with no difference in efficiency or bias and precision of estimates. Our results suggest that for clinical evaluations two appropriately timed samples (0.5 h after a 1-h infusion, trough concentration) are adequate for estimation for vancomycin clearance in neonates.
引用
收藏
页码:980 / 983
页数:4
相关论文
共 46 条
  • [31] Optimal sampling strategy for probability estimation: An application to the Agricultural Quarantine Inspection Monitoring program
    Ma, Huidi
    Leibowicz, Benjamin D.
    Hasenbein, John J.
    RISK ANALYSIS, 2024,
  • [32] Optimal Sampling Strategy and Threshold of Serum Vancomycin Concentration in Elderly Japanese Patients Undergoing High-Flux Hemodialysis
    Ogawa, Akio
    Hira, Daiki
    Tsujimoto, Masayuki
    Nishiguchi, Kohshi
    Endo, Masanori
    Ono, Toshiaki
    Hatta, Tsuguru
    Terada, Tomohiro
    Morita, Shin-ya
    THERAPEUTIC DRUG MONITORING, 2022, 44 (03) : 396 - 403
  • [33] Identifying the Optimal Sampling Strategy for the Bayesian Estimation of Vancomycin AUC0-24 in Adult Hematologic Cancer Patients
    Duong, Alexandre
    Le Blanc, Jessica
    Projean, Denis
    Marsot, Amelie
    CLINICAL PHARMACOKINETICS, 2025, 64 (02) : 297 - 305
  • [34] APPLICATION OF OPTIMAL SAMPLING THEORY TO THE DETERMINATION OF METACYCLINE PHARMACOKINETIC PARAMETERS - EFFECT OF MODEL MISSPECIFICATION
    TOD, M
    PADOIN, C
    LOUCHAHI, K
    MOREAUTOD, B
    PETITJEAN, O
    PERRET, G
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1994, 22 (02): : 129 - 146
  • [35] PROSPECTIVE USE OF OPTIMAL SAMPLING THEORY - STEADY-STATE CIPROFLOXACIN PHARMACOKINETICS IN CRITICALLY ILL TRAUMA PATIENTS
    YUEN, GJ
    DRUSANO, GL
    FORREST, A
    PLAISANCE, K
    CAPLAN, ES
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (04) : 451 - 457
  • [36] Evaluation of 5-FU pharmacokinetics in cancer patients with DPD deficiency using a Bayesian limited sampling strategy
    Van Kuilenburg, A.
    Hausler, P.
    Schalhorn, A.
    Tanck, M.
    Proost, J. H.
    Terborg, C.
    Behnke, D.
    Schwabe, W.
    Jabschinsky, K.
    Maring, J. G.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 478 - 478
  • [37] OPTIMAL SAMPLING THEORY AND POPULATION MODELING - APPLICATION TO DETERMINATION OF THE INFLUENCE OF THE MICROGRAVITY ENVIRONMENT ON DRUG DISTRIBUTION AND ELIMINATION
    DRUSANO, GL
    JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (10): : 962 - 967
  • [38] Determining the optimal re-sampling strategy for a classification model with imbalanced data using design of experiments and response surface methodologies
    Tong, Lee-Ing
    Chang, Yung-Chia
    Lin, Shan-Hui
    EXPERT SYSTEMS WITH APPLICATIONS, 2011, 38 (04) : 4222 - 4227
  • [39] AN OPTIMAL SAMPLING STRATEGY FOR DETERMINING CO2 EXCHANGE-RATE AS A FUNCTION OF PHOTOSYNTHETIC PHOTON FLUX-DENSITY
    HANSON, PJ
    MCROBERTS, RE
    ISEBRANDS, JG
    DIXON, RK
    PHOTOSYNTHETICA, 1987, 21 (01) : 98 - 101
  • [40] APPLICATION OF MODELING AND SIMULATION IN DESIGNING A PEDIATRIC CLINICAL OXYCODONE TRIAL WITH D-OPTIMAL SAMPLING STRATEGY.
    Venkatasubramanian, R.
    Dong, M.
    Fukuda, T.
    Goodhead, M. L.
    Vinks, A. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S100 - S100